Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...
On the third day of the month now known as “Dry January” for its new wellness focus, Surgeon General Vivek Murthy, M.D., issued a report that has created a buzz from liquor stores and restaurants to ...
TriSalus Life Sciences® Inc. , a biomedical technology company seeking to transform outcomes for patients with solid tumors by integrating its innovative delivery technology with standard-of-care ...
Cancer is the leading cause of death worldwide, responsible for nearly 10 million deaths in 2020, or about one in six deaths, ...
While lifestyle and environmental factors contribute to cancer risk, family history remains one of the most crucial yet often ...
As we begin the new year, many people might be thinking about improving their diet and overall health. As an oncology ...
The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 ...
Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...
Genetics significantly impact cancer risk, particularly in inherited mutations like BRCA1/BRCA2, which increase ...
This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. "IDEXX had a solid ...